Indication

Mydriasis

Mydriasis is the enlargement or dilation of the pupil beyond its normal physiological dimensions for a given level of ambient light. Read more about Mydriasis

55 drugs 25 manufacturers

Advertisement

Drugs that treat it

Common Mydriasis therapies.

Showing 37–45 of 55 drugs

ATROPINE SULFATE

OPHTHALMIC CYCLOPLEGICS/MYDRIATICS·CYCLOPLEGIA·+2
Alcon Laboratories

ATROPINE SULFATE

OPHTHALMIC CYCLOPLEGICS/MYDRIATICS·CYCLOPLEGIA·+2
NORTHSTAR RX LL
Filter & compare in the drug finder →Opens the drug finder with Mydriasis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Mydriasis.

Mydriasis is the enlargement or dilation of the pupil beyond its normal physiological dimensions for a given level of ambient light.

Affecting the ocular and autonomic nervous systems, it can occur pathologically across all age groups or be intentionally induced in ophthalmic settings to facilitate diagnostic fundoscopic examinations and intraocular surgical procedures.

Pathophysiologically, the state arises either from overstimulation of the sympathetic nervous system acting on the iris dilator pupillae muscle or from inhibition of parasympathetic cholinergic tone governing the iris sphincter pupillae muscle.

Its defining clinical manifestation is a sustained, widened pupil that demonstrates poor, sluggish, or absent constriction in response to direct light or near-fixation stimuli.

Personalize your experience

Follow Mydriasis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it